CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 44 enrolled
Drug / intervention
Videofluoroscopic Swallowing Study (VFSS)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04537650
NCT04537650N/ACompleted
CompareCT.gov

The Pathophysiology of Swallowing Impairment in People Recovering From COVID-19

University Health Network, Toronto·observational·Posted Sep 3, 2020·Updated Dec 6, 2023

In Brief

An observational study evaluating Videofluoroscopic Swallowing Study (VFSS) for Covid19. Completed, enrolled 44 participants across 2 sites in 2 countries.

Detailed Summary

This is an observational study, in which people recovering from COVID-19 infection will attend an outpatient clinic for a comprehensive swallowing assessment. The assessment will include a videofluoroscopy, measurement of respiratory-swallow coordination using a digital stethoscope, measures of tongue and cough strength and patient reported measures that will help us to understand the presence and impact of swallowing impairment (dysphagia) in this population.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCovid19
CountriesCanada, United States
CollaboratorsNational Institute on Deafness and Other Communication Disorders (NIDCD), McMaster University, University of Florida

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 3, 2020
Enrollment StartJan 1, 2021
Primary CompletionMar 31, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 5.8 years ago

Interventions

Videofluoroscopic Swallowing Study (VFSS)other

A standardized dynamic radiographic examination of oropharyngeal swallowing